March 31, 2026 NATRON Study: Design of a Phase 3 Trial of Benralizumab for Hypereosinophilic Syndrome (HES)
March 28, 2026 Time-Restricted Eating for Weight Loss and Metabolic Health in Polycystic Ovary Syndrome
